E V Denisov
Overview
Explore the profile of E V Denisov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
324
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Gerashchenko T, Zavyalova M, Denisov E, Krakhmal N, Pautova D, Litviakov N, et al.
Acta Naturae
. 2017 May;
9(1):56-67.
PMID: 28461975
Breast cancer (BC) demonstrates considerable intratumoral morphological heterogeneity. The aim of this work was to evaluate the relationship among different morphological structures, the rate of metastasis, and efficacy of neoadjuvant...
12.
Cherdyntseva N, Litviakov N, Denisov E, Gervas P, Cherdyntsev E
Exp Oncol
. 2017 Apr;
39(1):2-11.
PMID: 28361862
Each patient has a unique history of cancer ecosystem development, resulting in intratumor heterogeneity. In order to effectively kill the tumor cells by chemotherapy, dynamic monitoring of driver molecular alterations...
13.
Kaigorodova E, Tarabanovskaya N, Staheeva M, Savelieva O, Tashireva L, Denisov E, et al.
Neoplasma
. 2017 Mar;
64(3):437-443.
PMID: 28253723
Circulating tumor cells (CTCs) constitute a heterogeneous population. Some tumor cells are cancer stem cells (CSCs), while others are in the process of the epithelial-mesenchymal transition (EMT); however, most CTCs...
14.
Krakhmal N, Zavyalova M, Denisov E, Vtorushin S, Perelmuter V
Acta Naturae
. 2015 Jun;
7(2):17-28.
PMID: 26085941
Cancer invasion and the ability of malignant tumor cells for directed migration and metastasis have remained a focus of research for many years. Numerous studies have confirmed the existence of...
15.
Denisov E, Gerashchenko T, Zavyalova M, Litviakov N, Tsyganov M, Kaigorodova E, et al.
Neoplasma
. 2015 Feb;
62(3):405-11.
PMID: 25672673
In order to understand invasive/adhesive and drug resistant properties of intratumor morphological heterogeneity of breast cancer, we compared the expression of genes responsible for the cell adhesion and for the...
16.
Vtorushin S, Khristenko K, Zavyalova M, Perelmuter V, Litviakov N, Denisov E, et al.
Exp Oncol
. 2014 Sep;
36(3):144-56.
PMID: 25265346
Multi-drug resistance (MDR) is a condition when there is broad cross-resistance of cells to various agents which are different in structure and effect. Modern perceptions on mechanisms of MDR development...
17.
Gerashchenko T, Denisov E, Litviakov N, Zavyalova M, Vtorushin S, Tsyganov M, et al.
Biochemistry (Mosc)
. 2014 Jan;
78(11):1201-15.
PMID: 24460935
Intratumor heterogeneity inherent in the majority of human cancers is a major obstacle for a highly efficient diagnosis and successful prognosis and treatment of these diseases. Being a result of...
18.
Litviakov N, Garbukov E, Slonimskaia E, Tsyganov M, Denisov E, Vtorushin S, et al.
Vopr Onkol
. 2013 Aug;
59(3):334-40.
PMID: 23909034
Previously, we showed the association of neoadjuvant chemotherapy (NAC) response with changing the expression vector (increase or decrease) of multidrug resistance genes (MDR) in breast tumors during chemotherapy. The aim...
19.
Cherdyntseva N, Gervas P, Litvyakov N, Stakcheeva M, Ponomaryeva A, Dobrodeev A, et al.
Exp Oncol
. 2011 Mar;
32(3):205-8.
PMID: 21403619
Aim: To examine the influence of combined genotypes of TP53 (exon 4, intron 3, intron 6) and XRCC1 (codon 10) on lung cancer age of onset. Methods: TP53 polymorphisms in...
20.
Krikova E, Valdman E, Avakian G, Andreev I, Denisov E, Rider F, et al.
Zh Nevrol Psikhiatr Im S S Korsakova
. 2009 Dec;
109(10):57-62.
PMID: 20037572
An association between a polymorphism of the SCN1 gene, a therapeutical target of lamotrigine, and an effective dose (a blood plasma concentration) of the drug in patients with epilepsy has...